News 04. Febr. 2022 Test can recognize nine most common types of cancer Researchers at System Biologie AG from the Greater Zurich Area and HealthBiocare GmbH based in Vienna have discovered a new concept for the early...
Netzwerk Schweizerische Branchenverbände und Förderverbände Schweizer Branchenverbände mit internationaler Ausrichtung (Auswahl).
Aktuell 10. Aug. 2020 Helsinn eröffnet Anlage für Krebswirkstoffe Die Produktionstochter Helsinn Advanced Synthesis des Pharmakonzerns Helsinn hat in Biasca die bislang grösste Krebsabteilung in Betrieb genommen...
News 26. Jan. 2022 Ideogen improving accessibility of blood cancer therapy The Ideogen Group from the Greater Zurich Area is taking over the Special Access Program for Beleodaq in Europe, North Africa, the Middle East an...
Drittpartei Event "Kickoff: Value Excellence" mit Valuedesk, dem ISCM der Universität St. Gallen und Talent-net. Brunnen Schweiz
News 27. Sep 2021 University of Bern spin-off Arctos Medical acquired by Novartis Arctos Medical, a University of Bern spin-off developing optogenetic therapies for treating blindness, was acquired by Novartis.
Export Promotion Global Opportunities Opportunità di mercato a breve termine per le PMI svizzere: usufruite del nostro nuovo servizio e beneficiate di eccellenti opportunità di esport...
News 05. Mai 2023 Roche to found Institute for Human Biology Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will be tasked with promoting the b...
News 12. Jan. 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
Drittpartei Event Investitionen in asiatischen Ländern – Rechtliche und politische Rahmenbedingungen Bern Schweiz
News 29. Sep 2021 Researchers find proof of dementia in the blood The scientist Peter Nirmalraj is seeking to develop a simple blood test to help diagnose dementia. A pilot study carried out in conjunction with ...
Success stories 09. Juni 2022 La Svizzera offre condizioni interessanti e stabili per le aziende internazionali Merck Il leader scientifico e tecnologico Merck è presente in Svizzera da quasi un secolo. Oggi ha otto sedi, tra cui cinque impianti di produzione, e ...
News 08. Mai 2023 RetinAI partners with Boehringer Ingelheim to improve retinal disease treatment Bern-based RetinAI Medical, a pioneer in clinical and imaging data management software and advanced analytics using AI for ophthalmology, has joi...
News 26. Apr. 2023 Western Switzerland’s biotech sector flourishes amidst global challenges Western Switzerland's biotech industry continues to thrive, displaying resilience amidst global challenges. The region's unique ecosystem fosters...
Success stories 15. Sep 2020 Die Luye Life Sciences Group etabliert europäisches Hauptquartier in Basel Luye Pharma Mit seiner eigenen Produktpipeline und mehreren Tochtergesellschaften im Ausland ist Luye Pharma ein Pionier der chinesischen Pharmabranche. Das ...
News 05. Mai 2023 Alentis raises 105 million US dollars Alentis Therapeutics has received 105 million US dollars in a series C funding round. It will invest the funds in the phase I and II programs for...